| 发明名称 | Method for preventing nasolacrimal duct obstruction | ||
| 摘要 | The invention is directed to a method for preventing nasolacrimal duct obstruction (NLDO) in a patient receiving high dose radioactive iodine for treatment of cancer which comprises administering to the eyes of said patient an effective amount of perchlorate anion. | ||
| 申请公布号 | US9452133(B2) | 申请公布日期 | 2016.09.27 |
| 申请号 | US200511112553 | 申请日期 | 2005.04.25 |
| 申请人 | KEM Patent Holdings, LLC | 发明人 | Morgenstern Kenneth Eli |
| 分类号 | A61K51/00;A61K9/00;A61K33/14;A61K33/18;A61K33/40;A61K45/06;A61K33/20;A61K9/06;A61K9/08;A61K47/02 | 主分类号 | A61K51/00 |
| 代理机构 | Volpe and Koenig, P.C. | 代理人 | Volpe and Koenig, P.C. |
| 主权项 | 1. A method for preventing nasolacrimal duct obstruction in a patient receiving high dose radioactive iodine for treatment of cancer, the method comprises topically administering to the eyes of said patient of a therapeutically effective amount of perchlorate anion; wherein said perchlorate anion is administered at a dosage of from about 10 mg/ml to about 400 mg/ml, and said radioactive iodine is I131. | ||
| 地址 | Bryn Mawr PA US | ||